---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-201372"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:57:06.056043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics stockholders elect all six director nominees and ratify auditor at 2024 annual meeting

## Summary
- All six director nominees elected: Clowes, van Es-Johansson, Hawkins, Hedrick, Lenk, Petersen. Votes For ranged 1.16M-1.18M.
- Ratification of BDO USA as auditor for FY2024 approved: 2.43M For, 44,854 Against.
- Advisory say-on-pay approved: 1.12M For, 163,917 Against.
- Fourth amendment and restatement of 2020 Stock Incentive Plan approved: 1.10M For, 182,432 Against.

## SEC filing metadata
- accession: 0001193125-24-201372
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524201372/0001193125-24-201372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524201372/d864499d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-201372
- JSON: https://secwatch.observer/filing/0001193125-24-201372.json
- Plain text: https://secwatch.observer/filing/0001193125-24-201372.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.